INTRODUCTION
The immune and nervous systems are far more interconnected than originally thought. They sense and respond to danger, release shared mediators and generate and store memory.
Based on these similarities the immune system has been considered "the sixth sense" [1] [2] [3] . Our knowledge on neuroimmunology comes mainly from studies analyzing the effects of immune cells on the central nervous system, with limited information regarding the immune regulatory mechanisms of the peripheral nervous system [4] [5] [6] .
As professional Ag-presenting cells (APC) of the immune system, dendritic cells (DC)
play crucial roles in induction of T-cell immunity and tolerance. Accordingly, the possibility of administering therapeutic DC to regulate immunity in an Ag-specific manner has revolutionized the field of translational immunology over the past two decades 7 . Numerous methodologies have been developed to generate DC ex vivo that mimic the functions of tissue-resident orrecruited DC, with the intent to activate or suppress specific immunity [7] [8] [9] [10] [11] . In vitro-generated and/or -engineered therapeutic DC are highly desired for positive vaccination against intracellular pathogens or tumors, and for negative immunization protocols to treat autoimmune disorders or transplant rejection, respectively 12, 13 .
Considering the importance of neuropeptides in the regulation of immunity, the lack of information regarding their role on the biology of therapeutic DC is surprising. Substance P (SP), a prototypical pro-inflammatory neuropeptide of the tachykinin family secreted by δ -fibers, is crucial for induction of the neuroinflammatory reflex and perpetuation of inflammation and autoimmunity [14] [15] [16] . Likewise, the more recently described hemokinin-1 (HK-1) has strong proinflammatory effects 17 . These tachykinins exert their effects by binding with high affinity to the neurokinin-1 receptor (NK1R), a seven trans-membrane domain G-protein coupled receptor expressed as either a full length or a non-functional truncated isoform 18, 19 .
In a previous publication, we demonstrated that skin Langerhans' cells and bone marrow (BM)-derived DC (BMDC) express functional NK1R, and respond to NK1R agonists with
For personal use only. on . by guest www.bloodjournal.org From increased cell survival and migration to skin-draining lymph nodes (sDLN) 20, 21 . These immunological effects suggest that NK1R agonists could be employed as adjuvants for enhancing the efficiency of DC vaccines. Here, we demonstrate that conditioning BMDC with 
METHODS

Mice
8-12 week old WT C57BL/6, C57BL/6-129S1-Il12a tm1Jm /J (IL-12p35 KO ), -BFVB-Tg(Itgax-DTR/ EGFP)57Lan/J (CD11c-DTR), -Tg(TcraTcrb)1100Mjb/J (OT-I), and CCR2 KO mice were purchased from The Jackson Laboratory, housed in our pathogen-free facility, and used according to institutional (IACUC) guidelines.
Generation and stimulation of BMDC
BMDC were generated as described 21 and stimulated for 18 h with: i) the NK1R agonists SP, HK-1, (10 -5 or 10 -9 M, Bachem), or [Sar 9 Met (O 2 ) 11 ]-SP (10 -9 M, Sigma), ii) LPS (500 ng/ml, Sigma), or iii) agonist CD40 Ab (clone HM40-3, 10μg/ml, BD-PharMingen), and pulsed or not with OVA+OVA SIINFEKL peptide (1.0 mg/ml and 100 ng/ml, respectively) (Sigma) for 2 h. 20, 22 .
Quantitative RT-PCR was performed with commercially available primers specific for CREB1
and GAPDH (SABioscience) 21 . Relative quantitation of expression was determined by extrapolation to standard curve of cDNA from mouse brain. Data were normalized to the housekeeping gene GAPDH.
For western blot analysis of TORC2, cytoplasmic and nuclear proteins were extracted from BMDC using the NE-PER nuclear protein extraction kit (Thermo Scientific). Lysates were quantified using Pierce® BCA Protein Assay Kit (Thermo Scientific). Seventy five μ g of total protein were reduced with 2x Laemmli sample buffer containing 100mM DTT (10min, 70°C).
Protein samples were then resolved by SDS-PAGE in a Kd TM pre-cast gradient gel (BioRad) and transferred onto low fluorescence PVDF membranes (Thermo Scientific). Blots were blocked with Odyssey Blocking buffer (Licor) (1h, RT) before probing with primary Ab (overnight, 4°C). Proteins were visualized with secondary Ab conjugated to IRDye® (1h, RT), and scanned using Odyssey Imaging System (Licor). The following Ab were employed: rabbit anti-βactin, rabbit anti-histone H3 (Cell Signaling Technology), and rat anti-TORC2 (R&D Systems). Band densities were quantified using the Image Studio Software version 2 (Licor).
Analysis of BMDC phenotype and cytokines
The 20 .
In vitro Ag-presentation assays
Splenic OT-I-CD8 T cells were purified by negative selection (R&D Systems). Ag-DC, NK1R-DC, or Ag-NK1R-DC generated form WT or CCR7 KO C57BL/6 mice were co-cultured with OT-I Experiments analyzing T-cell proliferation were performed as described 20 . Secretion of IFN-γ (BD-PharMingen), IL-5, IL-13 and IL-12p70 (eBioscience) were analyzed by ELISA 20, 21 .
Induction of OVA-specific T cells in vivo
Ag-DC, NK1R-DC, or Ag-NK1R-DC generated from C57BL/6 mice were injected (2x10 6 , footpad) in C57BL/6 mice (n=6 / group). Controls included untreated mice and mice immunized with untreated DC. Five days later, mice were euthanized, and IFN-γ, IL-5, and IL-13 secretion
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After skin-immunization, Ag-specific in vivo killing assays and detection of cytokine secretion by specific CD8 T cells after ex vivo Ag re-stimulation was conducted as previously described 20 .
In vivo depletion of DC C57BL/6 CD11c-DTR mice were injected with diphtheria toxin (DT) (4 ng / g body weight) or PBS (control), 1 day before immunization (footpad) with Ag-DC, NK1R-DC, or Ag-NK1R-DC.
Ag-specific secretion of IFN-γ by splenic CD4 T cells was evaluated in ELISPOT assays, and
Ag-specific CTL function was assessed by in vivo killing assays, as published 20 .
Recombinant adenoviral (RAd) transduction of BMDC
BMDC were infected with RAd-IL-10, or with RAd-Empty (MOI=100) as published 22 . RAd transduction was assessed by ELISA (BD-PharMingen) based on the amount of IL-10 secreted into culture supernatants over a 24 h period from RAd-transduced BMDC.
Microscopic analysis
Inguinal LN from mice untreated or BMDC-immunized (footpad) were fixed in 4% formaldehyde, paraffin-embedded, sectioned, and stained with H&E or periodic acid-Schiff (PAS). For characterization of leukocyte subsets, LN were snap-frozen 20 sectioned and stained with Alexa-fluor-488-CD11c Ab, Alexa-fluor-647-CD11b Ab or Alexa-fluor-647-CD3 Ab, and biotinLy6C followed by streptavidin-Cy3 (eBioscience, BD-PharMingen, Jackson ImmunoResearch).
For DTH assays, skin samples were processed for H&E staining or labeled with biotin-CD3 Ab or biotin-F4/80 Ab, followed by streptavidin-peroxidase. Microscopic images were examined with an Axiostar plus microscope (Zeiss), equipped with epifluorescence and a digital camera 
Delayed-type hypersensitivity assays (DTH)
C57BL/6 mice (6 per group) were sensitized (footpad) or not with 1 dose (2x10 6 ) of Ag-DC, or
Ag-NK1R-DC, infected or not with RAd-IL-10. After 7 days, mice were injected (i.d.) on the dorsal side of the ears with OVA (1mg/ 50μl/PBS). The severity of the DTH was assessed as previously described 20, 21 .
Statistical analysis
Differences between more than 2 means ± 1SD were analyzed by a 1-way ANOVA analysis followed by a Student Newman Keuls test. Comparisons between 2 different means ± 1SD
were performed by a Student's "t" test. A p value <0.05 was considered significant. Statistical analysis was performed using the GraphPad Prism® 4 software (GraphPad Software).
RESULTS
NK1R signaling promotes mature BMDC unable to secrete IL10
The finding that pro-inflammatory neuropeptides are released at high concentrations in inflammatory and autoimmune disorders prompted us to explore their potential use as adjuvants in the generation of immunostimulatory DC for the purpose of future cell vaccine development 24, 25 . To assess whether signaling through NK1R increases BMDC maturation and T-cell stimulatory functions, BMDC were left untreated (DC, control) or stimulated via NK1R
(NK1R-DC) with the synthetic and exclusive NK1R agonist [Sar 9 Met (O 2 ) 11 ]-SP (SarSP) 22 , or the naturally occurring NK1R agonists SP and HK-1 (the latter not shown). Untreated DC or NK1R-DC were next pulsed or not with OVA+OVA SIINFEKL (Ag-DC and Ag-NK1R-DC, respectively). 
NK1R-DC promote cellular immunity that requires IL-12p70
Next, we tested whether NK1R agonists generate BMDC that stimulate type-1 biased immunity in vivo. WT C57BL/6 mice were immunized (footpad) with untreated DC (control), NK1R-DC, Ag-DC, or Ag-NK1R-DC. Immunization with Ag-DC elicited a mixed Th1/Th2 response, and weak Tc1/CTL immunity ( Figure 2 ). In contrast, Ag-NK1R-DC promoted robust Th1 (Figure 2A) and Tc1 ( Figure 2B ) responses, and significantly superior CD8 CTL function ( Figure 2C ).
Since our results indicate that despite of producing negligible levels of IL-12p70, Ag-NK1R-DC initiate type-1 immunity, we investigated whether this response required IL-12p70, and if so, which was the cellular source secreting IL-12p70. To address this question, we vaccinated (footpad) WT or IL-12p35 KO C57BL/6 mice with untreated-DC (control), Ag-DC, or
Ag-NK1R-DC generated from either WT or IL-12p35 KO C57BL/6 mice. These experiments demonstrated that IFN-γ secretion by CD4 T cells and the CTL function mediated by CD8 T cells required IL-12p70 ( Figure 3A and B). Opposite to an IL-12-independent mechanism, the type-1 responses observed required IL-12p70 and decreased significantly in host IL-12p35 KO mice injected with WT DC, demonstrating that IL-12p70 was produced mainly by host cells and not the injected DC vaccine ( Figure 3A and B). The critical role of host-derived IL-12p70 in our Figure 3C ).
To investigate whether the source of IL-12p70 in our model was host DC, endogenous Figure 4A ). Reduction of CREB1 levels in NK1R-DC was further investigated by qRT-PCR, which confirmed that agonistic signaling of BMDC via NK1R decreases significantly CREB1 transcripts ( Figure 4B ).
In addition to CREB1, the recently described CREB1-specific co-activator-2 (TORC2) participates activating Il-10 promoter 26, 27 . Hence, we investigated whether in addition to CREB1
inhibition, NK1R-DC have deficient activation and nuclear translocation of TORC2. We 
Immunity induced by NK1R-DC requires their homing in sDLN
There is increasing evidence that DC generated ex vivo can be effectively employed for positive vaccination to stimulate T-cell function through interactions with host DC in lymphoid organs [28] [29] [30] .
First, we investigated whether NK1R-DC were better equipped than untreated DC to interact with DC and T cells in sDLN by assessing the expression of DC-DC and DC-T cell adhesion molecules including, CD11a, CD11b, CD18, CD54, CD102 and CD209. We also analyzed if CCR7 was required for the injected DC to home in sDLN to exert their enhanced T-cell stimulatory functions in vivo. NK1R-DC and Ag-NK1R-DC increased significantly the levels of surface CCR7, CD11b, CD18, and CD54 compared to untreated DC and Ag-DC ( Figure 5A ). Figure 5D ). LN-homing of Ag-NK1R-DC was necessary for exerting their T-cell stimulatory function as demonstrated by CTL function abrogation following immunization of WT mice with Ag-NK1R-DC generated from syngenic CCR7 KO mice ( Figure 5E ). Importantly, NK1R-signaled CCR7 KO BMDC expressed high levels of surface CD86
and effectively stimulated OVA-specific (OT-I) CTL in vitro (not shown), suggesting that their defect in inducing specific type-1 T-cell responses in vivo was due to their inability to home in sDLN. Therefore, NK1R-DC are required to home in sDLN where they likely interact with host DC to elicit type-1 immunity. Figure 6A and B) . Under such conditions, inflammatory DC and conventional CD8α + DC contained intracellular IL-12 ( Figure   6C ). By contrast, IL-12 was undetectable in sDLN of mice vaccinated with Ag-NK1R-DC secreting transgenic IL-10 ( Figure 6C ). Intracellular secretion of IL-12 was detected 1 day following administration of Ag-NK1R-DC, peaked on day 2, and decreased thereafter ( Figure   6D ). These results provide evidence that down-regulation of IL-10 by Ag-NK1R-DC releases the inhibitory effect of IL-10 on IL-12 secretion by endogenous DC in sDLN.
Immunity induced by NK1R-DC requires LN recruitment of inflammatory DC
To confirm that inflammatory DC are critical for the promotion of type-1 immunity in our Figure 6C) . Importantly, CTL function in CCR2 KO mice vaccinated with Ag-NK1R-DC was significantly diminished compared to that observed in WT animals ( Figure 6E ). These findings demonstrate that recruitment of inflammatory DC to sDLN is required for the induction of the IL-12-dependent type-1 immunity that follows vaccination with NK1R-DC.
NK1R-DC promote type-1 effector immunity that is prevented by IL-10
Thus 
DISCUSSION
Signaling via NK1R, a shared receptor of the pro-inflammatory tachykinins SP and HK-1, triggers neurogenic inflammation and influences immunity outcome [31] [32] [33] . Nevertheless, the impact of NK1R-signaling on DC, key regulators of the immune system, remains poorly investigated. In the present study, we analyzed the effects and mechanisms of NK1R-signaling of ex vivo generated DC, the gold standard for DC-based vaccines 7, 8, 12 . Our results demonstrate that NK1R-stimulation promotes DC maturation, with increased expression of Ag-presenting, costimulatory and adhesion molecules. These changes contributed to the DC ability to migrate
For personal use only. on April 13, 2017. by guest www.bloodjournal.org From efficiently from injection sites to the paracortical area of sDLN and promote potent type-1 immunity. Importantly, NK1R-signaled DC showed decreased synthesis and secretion of IL-10 that regulates negatively IL-12. Consequently, when NK1R-DC were injected as a cell vaccine, they homed in sDLN in close proximity to T cells and licensed host DC to secrete IL-12, resulting in robust type-1 immunity.
NK1R-signaling by SP has been associated with the onset of autoimmune disorders, including psoriasis, rheumatoid arthritis, and inflammatory bowel disease and the severity of the symptoms in such experimental models is exacerbated in IL-10 KO mice [34] [35] [36] . Indeed, IL-10 is one of the most potent anti-inflammatory cytokines that contributes to maintain peripheral tolerance and tissue homeostasis in the steady state [37] [38] [39] . In our model, NK1R agonists blocked the CREB1/TORC2 pathway in BMDC, decreasing
Il-10 gene transcription and abrogating IL-10 secretion. Moreover, this IL-10 inhibitory effect of NK1R agonists persisted following the induction of high levels of IL-10 by LPS 26, 40 . According to its pro-inflammatory potential, NK1R-signaling of BMDC reduced the transcriptional function of CREB1 while increasing nuclear translocation of NF-κB, which explains why NK1R agonists promote the differentiation of pro-inflammatory APC 26, 40 .
Over the past two decades, several laboratories have emphasized the need to generate optimally stimulated DC ex vivo capable of secreting high levels of IL-12p70 to promote type-1-biased immunity for the purpose of positive vaccinations 7, 8, 42, 43 . To be effective, these therapeutic DC1 (administered in peripheral tissues) should retain their capability to secrete IL12p70 when they encounter Ag-specific T cells in secondary lymphoid organs 44 . For personal use only. on . by guest www.bloodjournal.org From
